U.S. government begins two trials testing Eli Lilly's coronavirus antibody drug
August 04, 2020 at 11:00 AM EDT
The trials, called ACTIV-2 and ACTIV-3, will look at U.S. drugmaker Eli Lilly's experimental treatment known as LY-CoV555, which is being developed in partnership with Canadian biotech AbCellera.
